Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steroid-sparing strategies.

C Ponticelli1

  • 1IRCCS Istituto Scientifico Auxologico, Milano, Italy. claudio.ponticelli@fastwebnet.it

Transplantation Proceedings
|January 3, 2006
PubMed
Summary
This summary is machine-generated.

Early corticosteroid withdrawal in organ transplant recipients is feasible, potentially reducing side effects without impacting graft survival. This steroid-sparing approach improves patient compliance and long-term outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Should we really STOP treating patients with IgA nephropathy with steroids?

Physiology international·2018
Same author

Synthetic pharmacotherapy for lupus nephritis.

Expert opinion on pharmacotherapy·2017
Same author

Hydroxychloroquine in systemic lupus erythematosus (SLE).

Expert opinion on drug safety·2016
Same author

A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids?

Transplantation proceedings·2014
Same author

Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years.

Lupus·2013
Same author

Present and future of immunosuppressive therapy in kidney transplantation.

Transplantation proceedings·2011
Same journal

Acute Rejection Mediated by Preformed Anti-HLA-C Antibody in a Kidney Transplant Patient: A Case Report.

Transplantation proceedings·2026
Same journal

Liver Transplantation for Metastatic Neuroendocrine Tumors: A Single-Center Experience in a Brazilian Referral Center.

Transplantation proceedings·2026
Same journal

Analysis of the Cost of Maintaining Effective Donors and Nondonors of Organs and Tissues in Intensive Care Units.

Transplantation proceedings·2026
Same journal

Adolescence and Pediatric Heart Transplantation: Impact of Non-Adherence on Mortality: A Single-Center Experience.

Transplantation proceedings·2026
Same journal

Impact of Family-Based Care on the Outcome of Brain Death and Humanization in the Process of Multiple Organ Donation: Case Report.

Transplantation proceedings·2026
Same journal

Karnofsky Performance Status Is Associated with Patient and Graft Survival After Liver Retransplantation.

Transplantation proceedings·2026
See all related articles

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation Medicine

Background:

  • Corticosteroids are standard immunosuppressants in organ transplantation but cause significant side effects.
  • Cyclosporine and newer agents have enabled trials investigating corticosteroid avoidance or withdrawal.

Purpose of the Study:

  • To evaluate the feasibility and outcomes of early corticosteroid elimination in renal transplant recipients.
  • To assess the impact of steroid-sparing strategies on rejection rates, graft survival, and complications.

Main Methods:

  • Meta-analyses of randomized trials comparing steroid avoidance/withdrawal with continued steroid use.
  • Long-term follow-up data from multicenter trials using cyclosporine and newer immunosuppressants like everolimus.

Related Experiment Videos

Main Results:

  • Early steroid avoidance may increase acute rejection but does not negatively affect long-term graft survival.
  • Steroid withdrawal is associated with reduced cardiovascular, ocular, and bone complications.
  • Recent studies show similar patient and graft survival with early steroid cessation and low-dose prednisone.

Conclusions:

  • Early elimination of corticosteroids is a viable strategy for many renal transplant recipients.
  • Steroid-sparing protocols can mitigate adverse effects and enhance patient adherence.
  • Optimizing immunosuppression with reduced corticosteroid use is a key goal in transplantation.